4.5 Article

Concurrent Bacteremia Due to Non-vaccine Serotype 24F Pneumococcus in Twins: A Rapid Increase in Serotype 24F-invasive Pneumococcal Disease and its High Invasive Potential

期刊

PEDIATRIC INFECTIOUS DISEASE JOURNAL
卷 39, 期 1, 页码 85-87

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/INF.0000000000002508

关键词

Streptococcus pneumoniae; invasive pneumococcal disease; twin; serotype

资金

  1. Ministry of Health, Labor and Welfare of Japan [H19-iyaku-ippan-032, H22-shinko-shitei-021, H25-shinko-shitei-003]
  2. Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development (AMED) [JP18fk0108015]

向作者/读者索取更多资源

Although concurrent bacteremia in siblings is rare, serotype 24F Streptococcus pneumoniae was isolated from the blood of twin 1-year-old girls within a 3-day interval, supporting the high invasive potential of this serotype. As the prevalence of childhood serotype 24F-invasive pneumococcal diseases increases in Europe and the Western Pacific Region, investigation and surveillance of this serotype are necessary.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Successful Salvage of Very Early Relapse in Pediatric Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin and HLA-haploidentical Peripheral Blood Stem Cell Transplantation With Posttransplant Cyclophosphamide

Takanari Abematsu, Takuro Nishikawa, Shunsuke Nakagawa, Yuichi Kodama, Yasuhiro Okamoto, Yoshifumi Kawano

Summary: In this case report, a 14-year-old female patient with relapsed B-cell precursor acute lymphoblastic leukemia achieved minimal residual disease-negative complete remission after receiving inotuzumab ozogamicin therapy. She subsequently underwent haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide, leading to complete remission at 23 months. This combined treatment strategy may be effective for pediatric refractory acute lymphoblastic leukemia.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2022)

Article Microbiology

Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project

Julia C. Bennett, Marissa K. Hetrich, Maria Garcia Quesada, Jenna N. Sinkevitch, Maria Deloria Knoll, Daniel R. Feikin, Scott L. Zeger, Eunice W. Kagucia, Adam L. Cohen, Krow Ampofo, Maria-Cristina C. Brandileone, Dana Bruden, Romina Camilli, Jesus Castilla, Guanhao Chan, Heather Cook, Jennifer E. Cornick, Ron Dagan, Tine Dalby, Kostas Danis, Sara de Miguel, Philippe De Wals, Stefanie Desmet, Theano Georgakopoulou, Charlotte Gilkison, Marta Grgic-Vitek, Laura L. Hammitt, Markus Hilty, Pak-Leung Ho, Sanjay Jayasinghe, James D. Kellner, Jackie Kleynhans, Mirjam J. Knol, Jana Kozakova, Karl G. Kristinsson, Shamez N. Ladhani, Laura MacDonald, Grant A. Mackenzie, Lucia Mad'arova, Allison McGeer, Jolita Mereckiene, Eva Morfeldt, Tuya Mungun, Carmen Munoz-Almagro, J. Pekka Nuorti, Metka Paragi, Tamara Pilishvili, Rodrigo Puentes, Samir K. Saha, Aalisha Sahu Khan, Larisa Savrasova, J. Anthony Scott, Anna Skoczynska, Shigeru Suga, Mark van der Linden, Jennifer R. Verani, Anne von Gottberg, Brita A. Winje, Inci Yildirim, Khalid Zerouali, Kyla Hayford

Summary: The study showed that PCV10/13 had a significant impact in reducing the incidence of Streptococcus pneumoniae serotype 1 (ST1) invasive pneumococcal disease across all age groups. After approximately 6 years of PCV10/13 use in infant immunization programs, there was a substantial reduction in ST1 IPD incidence rates across all age groups.

MICROORGANISMS (2021)

Article Microbiology

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project

Maria Deloria Knoll, Julia C. Bennett, Maria Garcia Quesada, Eunice W. Kagucia, Meagan E. Peterson, Daniel R. Feikin, Adam L. Cohen, Marissa K. Hetrich, Yangyupei Yang, Jenna N. Sinkevitch, Krow Ampofo, Laurie Aukes, Sabrina Bacci, Godfrey Bigogo, Maria-Cristina C. Brandileone, Michael G. Bruce, Romina Camilli, Jesus Castilla, Guanhao Chan, Grettel Chanto Chacon, Pilar Ciruela, Heather Cook, Mary Corcoran, Ron Dagan, Kostas Danis, Sara de Miguel, Philippe De Wals, Stefanie Desmet, Yvonne Galloway, Theano Georgakopoulou, Laura L. Hammitt, Markus Hilty, Pak-Leung Ho, Sanjay Jayasinghe, James D. Kellner, Jackie Kleynhans, Mirjam J. Knot, Jana Kozakova, Karl Gustaf Kristinsson, Shamez N. Ladhani, Claudia S. Lara, Maria Eugenia Leon, Tiia Lepp, Grant A. Mackenzie, Lucia Mad'arova, Allison McGeer, Tuya Mungun, Jason M. Mwenda, J. Pekka Nuorti, Nehemie Nzoyikorera, Lucia Helena De Oliveira, Metka Paragi, Tamara Pilishvili, Rodrigo Puentes, Eric Rafai, Samir K. Saha, Larisa Savrasova, Camelia Savulescu, J. Anthony Scott, Kevin J. Scott, Fatima Serhan, Lena Petrova Setchanova, Nadja Sinkovec Zorko, Anna Skoczynska, Todd D. Swarthout, Palle Valentiner-Branth, Mark van Der Linden, Didrik E. Vestrheim, Anne von Gottberg, Inci Yildirim, Kyla Hayford

Summary: This study provides a comprehensive overview of serotype-specific IPD surveillance in countries using PCV10/13, with a focus on the PSERENADE project. The analysis includes data from multiple sites across geographic regions and different vaccination schedules, aiming to estimate the impact of PCV and inform decision-making at national and global levels.

MICROORGANISMS (2021)

Article Microbiology

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project

Maria Garcia Quesada, Yangyupei Yang, Julia C. Bennett, Kyla Hayford, Scott L. Zeger, Daniel R. Feikin, Meagan E. Peterson, Adam L. Cohen, Samanta C. G. Almeida, Krow Ampofo, Michelle Ang, Naor Bar-Zeev, Michael G. Bruce, Romina Camilli, Grettel Chanto Chacon, Pilar Ciruela, Cheryl Cohen, Mary Corcoran, Ron Dagan, Philippe De Wals, Stefanie Desmet, Idrissa Diawara, Ryan Gierke, Marcela Guevara, Laura L. Hammitt, Markus Hilty, Pak-Leung Ho, Sanjay Jayasinghe, Jackie Kleynhans, Karl G. Kristinsson, Shamez N. Ladhani, Allison McGeer, Jason M. Mwenda, J. Pekka Nuorti, Kazunori Oishi, Leah J. Ricketson, Juan Carlos Sanz, Larisa Savrasova, Lena Petrova Setchanova, Andrew Smith, Palle Valentiner-Branth, Maria Teresa Valenzuela, Mark van der Linden, Nina M. van Sorge, Emmanuelle Varon, Brita A. Winje, Inci Yildirim, Jonathan Zintgraff, Maria Deloria Knoll

Summary: Introduction of PCV has reduced pneumococcal meningitis incidence, with remaining cases showing different serotype distribution in countries using PCV10/13 for at least 5-7 years. Higher-valency PCVs may target over half of remaining cases, but further data is needed for generalizability in the African meningitis belt.

MICROORGANISMS (2021)

Article Obstetrics & Gynecology

Primary cytomegalovirus infection during pregnancy and congenital infection: a population-based, mother-child, prospective cohort study

Kyoko Shimada, Kuniaki Toriyabe, Asa Kitamura, Fumihiro Morikawa, Toshio Minematsu, Makoto Ikejiri, Shigeru Suga, Hidemi Toyoda, Keishiro Amano, Masako Kitano, Satoko Usui, Sawako Masuda, Tomoaki Ikeda

Summary: The study found that teenage mothers and those with parity >= 2 are at higher risk for post-primary congenital cytomegalovirus infection. Among the 22 live birth congenital infection cases, three had abnormal neurological findings.

JOURNAL OF PERINATOLOGY (2021)

Article Pediatrics

The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan

Tomohiro Katsuta, Naoki Shimizu, Kenji Okada, Keiko Tanaka-Taya, Takashi Nakano, Hajime Kamiya, Kiyoko Amo, Naruhiko Ishiwada, Satoshi Iwata, Makoto Oshiro, Nobuhiko Okabe, Ryutaro Kira, Seigo Korematsu, Shigeru Suga, Takeshi Tsugawa, Naoko Nishimura, Haruka Hishiki, Masashi Fujioka, Mitsuaki Hosoya, Yumi Mizuno, Mahito Mine, Isao Miyairi, Chiaki Miyazaki, Ichiro Morioka, Tsuneo Morishima, Tetsushi Yoshikawa, Taizo Wada, Hiroshi Azuma, Koichi Kusuhara, Kazunobu Ouchi, Akihiko Saitoh, Hiroyuki Moriuchi

Summary: The study in Japan focused on pediatric COVID-19 cases reported by pediatricians, finding that children mostly experience mild or asymptomatic cases. Household transmission is the main route of transmission, and school closure had limited impact on COVID-19 spread among children.

PEDIATRICS INTERNATIONAL (2022)

Article Obstetrics & Gynecology

Characteristics and serology of pregnant women with cytomegalovirus immunoglobulin G seroconversion during pregnancy in Japan

Kyoko Shimada, Kuniaki Toriyabe, Asa Kitamura, Fumihiro Morikawa, Makoto Ikejiri, Toshio Minematsu, Haruna Nakamura, Shigeru Suga, Tomoaki Ikeda

Summary: Among pregnant women, teenagers have a significantly higher rate of CMV IgG seroconversion, and the titer of CMV IgM at the time of IgG seroconversion may help predict the occurrence of fetal congenital CMV infection.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2021)

Article Microbiology

Whole-Genome Analysis-Based Phylogeographic Investigation of Streptococcus pneumoniae Serotype 19A Sequence Type 320 Isolates in Japan

Satoshi Nakano, Takao Fujisawa, Bin Chang, Yutaka Ito, Hideki Akeda, Jiro Fujita, Yasufumi Matsumura, Masaki Yamamoto, Shigeru Suga, Kazunori Oishi, Miki Nagao, Makoto Ohnishi

Summary: By analyzing pneumococcal isolates collected in Japan, it was found that the globally distributed 19A-ST320 clone may have already spread in the United States.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Oncology

Changes in intracellular activation-related gene expression and induction of Akt contribute to acquired resistance toward nelarabine in CCRF-CEM cell line

Almitra Rindiarti, Yasuhiro Okamoto, Shunsuke Nakagawa, Junko Hirose, Yuichi Kodama, Takuro Nishikawa, Yoshifumi Kawano

Summary: Drug resistance is a significant problem in nelarabine treatment, and this study aimed to understand the underlying mechanisms. Two nelarabine-resistant subclones were established and changes in gene expression related to nelarabine activation and apoptosis inhibition were observed. Akt protein activation was also observed in these resistant subclones. Combination treatment with nelarabine and PI3K/Akt inhibitors showed inhibitory effects on cell growth. Cross-resistance was observed with ara-C but not with vincristine, daunorubicin, or etoposide. Changes in gene expression, apoptosis inhibition, and Akt induction may contribute to the development of nelarabine resistance. The use of different classes of chemotherapeutic agents and combination therapy with PI3K/Akt pathway inhibitors can potentially overcome resistance to nelarabine.

LEUKEMIA & LYMPHOMA (2022)

Editorial Material Pediatrics

Is aseptic meningitis following mumps vaccination underreported in Japan?

Yusuke Uozumi, Masazumi Miyahara, Kyoko Osaki, Manami Negoro, Shigeru Suga

PEDIATRICS INTERNATIONAL (2022)

Article Hematology

Ponatinib in pediatric patients with Philadelphia chromosome-positive leukemia: a retrospective survey of the Japan Children's Cancer Group

Yuichi Kodama, Atsushi Sato, Keisuke Kato, Hirotoshi Sakaguchi, Motohiro Kato, Hirohide Kawasaki, Hidefumi Hiramatsu, Itaru Kato, Takashi Taga, Hiroyuki Shimada

Summary: The clinical courses of pediatric patients with Ph+ ALL and CML who received ponatinib therapy were retrospectively reviewed. Most patients responded well to ponatinib, but a proportion of patients experienced adverse reactions.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2022)

Article Infectious Diseases

Rapid Spread in Japan of Unusual G9P[8] Human Rotavirus Strains Possessing NSP4 Genes of E2 Genotype

Saori Fukuda, Yuki Akari, Riona Hatazawa, Manami Negoro, Takaaki Tanaka, Kazutoyo Asada, Haruna Nakamura, Katsumi Sugiura, Masakazu Umemoto, Haruo Kuroki, Hiroaki Ito, Shigeki Tanaka, Mitsue Ito, Tomihiko Ide, Takayuki Murata, Kiyosu Taniguchi, Shigeru Suga, Hajime Kamiya, Takashi Nakano, Koki Taniguchi, Satoshi Komoto

Summary: The emergence and rapid spread of unusual G9P[8]-E2 human rotaviruses in the Tokyo metropolitan area, Japan in 2018 has been reported. The G9P[8]-E2 strains detected in children with diarrhea from different regions of Japan were found to have a unique genotype configuration that originated from reassortment between G9P[8]-E1 and G2P[4]-E2 strains. Notably, the G9P[8]-E2 strains showed a high degree of similarity in their genome sequences, suggesting a common origin.

JAPANESE JOURNAL OF INFECTIOUS DISEASES (2022)

Article Infectious Diseases

High prevalence of IgE sensitization to inactivated influenza vaccines, yet robust IgG4 responses, in a healthy pediatric population

Prince Baffour Tonto, Mizuho Nagao, Shigeru Suga, Kiyosu Taniguchi, Masahiro Hirayama, Tetsuo Nakayama, Takuji Kumagai, Takao Fujisawa

Summary: Inactivated influenza vaccines can induce allergic reactions in healthy children, but they can also trigger strong IgG4 responses that may protect them from allergic reactions.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Article Microbiology

Nationwide and long-term molecular epidemiologic studies of mumps viruses that circulated in Japan between 1986 and 2017

Minoru Kidokoro, Teiichiro Shiino, Tomohiro Yamaguchi, Eri Nariai, Hiroe Kodama, Keiko Nakata, Takako Sano, Keiko Gotou, Tomoko Kisu, Tomomi Maruyama, Yumani Kuba, Wakako Sakata, Teruaki Higashi, Naoko Kiyota, Takashi Sakai, Shunsuke Yahiro, Akira Nagita, Kaori Watanabe, Chika Hirokawa, Hirotsune Hamabata, Yoshiki Fujii, Miwako Yamamoto, Hajime Yokoi, Misako Sakamoto, Hiroyuki Saito, Chihiro Shibata, Machi Inada, Misako Fujitani, Hiroko Minagawa, Miyabi Ito, Akari Shima, Keiko Murano, Hiroshi Katoh, Fumihiro Kato, Makoto Takeda, Shigeru Suga

Summary: This study reveals the nationwide and long-term molecular epidemiology of mumps virus in Japan, identifying different genotypes and observing changes in dominant genotypes over different decades. The analysis based on whole-genome sequencing shows that this is a powerful tool for accurate molecular epidemiology studies.

FRONTIERS IN MICROBIOLOGY (2022)

Article Virology

Revision of Cytomegalovirus Immunoglobulin M Antibody Titer Cutoff in a Maternal Antibody Screening Program in Japan: A Cohort Comparison Involving a Total of 32,000 Pregnant Women

Asa Kitamura, Kuniaki Toriyabe, Miki Hagimoto-Akasaka, Kyoko Hamasaki-Shimada, Makoto Ikejiri, Toshio Minematsu, Shigeru Suga, Eiji Kondo, Masamichi Kihira, Fumihiro Morikawa, Tomoaki Ikeda

Summary: To validate the revised CMV immunoglobulin M (IgM) titer cutoff for IgG avidity measurements as a reflex test, maternal CMV antibodies were screened using the Denka assay in Japan from 2017 to 2019. The revised IgM cutoff improved maternal screening in identifying primary CMV infection and newborn cCMV, with comparable results to those obtained using the original cutoff. However, further research using alternative assays is needed.

VIRUSES-BASEL (2023)

暂无数据